Skip to main content
search
0

Niktimvo (axatilimab-csfr)

  • Medicine Name: Niktimvo
  • API: Axatilimab-csfr
  • Dosage Form & Strength: Injection: 50 mg/mL solution in a single-dose vial
  • Manufactured By: Incyte Corporation

Niktimvo (axatilimab-csfr) is a colony-stimulating factor-1 receptor (CSF-1R)–blocking antibody used for the treatment of chronic graft-versus-host disease (cGVHD) after the failure of at least two prior lines of systemic therapy in adult and pediatric patients weighing at least 40 kg.

Recommended Dosage: The recommended dosage of Axatilimab-csfr for adults and pediatric patients weighing 40 kg and above is 0.3 mg/kg, with a maximum dose of 35 mg, administered every 2 weeks. Axatilimab-csfr injection is given as an intravenous infusion for over 30 minutes. Ensure proper dosage for effective treatment while minimizing risks. Consult your healthcare provider (HCP) for accurate dosage and guidelines.

Contact Patient Support

If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.

Disclaimer

All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.

Close Menu

How can I Help You?